The molecular phenotype of basal breast cancers has been shown to be repressed by FOXA1 expression, which is associated with the luminal phenotype.13 These findings raise the possibility that BRCA1 and FOXA1 interact at the molecular level to modulate the development of basal and luminal breast cancer subtypes. The gene discussed is BRCA1; the disease is breast cancer.